Pharmaceutical Investing Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
Pharmaceutical Investing Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection
Pharmaceutical Investing Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
Pharmaceutical Investing Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX for Injection
Forte Minerals Commences First-Ever Drilling at the Pucarini High-Sulfidation Gold Project, Puno, Peru
Homerun Resources Inc. Announces First Commercial Installation of "The Hub" AI Energy Management System on a Risen Battery Storage Asset
Blue Sky Uranium Completes Comprehensive GAP Analysis for Ivana Deposit and Identifies Clear Roadmap to Feasibility
Homerun Resources Inc. Receives Conditional Approval from the TSXV for $6 Million Financing with Institutional Investor
